Drug Security Forum

Import Substitution and Exports for the New Times: Solutions that Strengthen Local Players

14 Jun , 10:00–11:30
‘Ensuring Drug Security’ Russian Pharmaceutical Forum
Pavilion G, conference hall G7

The policy of import substitution was established back in the early stages of development of the domestic pharmaceutical industry. Today, in the context of global challenges, the issue of drug security is no longer a theory, but a modern Russian reality. The national pharmaceutical industry is faced with the task of developing timely strategies to respond to the current agenda, the highest priority requirements of which include ensuring continuity of supply of strategically important medicines and medical devices, achieving technological sovereignty for the industry, and maintaining competitiveness in foreign markets, which the biggest Russian manufacturers have successfully achieved. What are Russian companies preparing for today, what kind of strategies are they choosing, and to what extent do those tally with the government’s demands? Is it possible to talk about trends in intensifying production cycles? What barriers currently stand in the way of achieving technological sovereignty? What measures can support the development of high-tech exports now that sanctions have been imposed? Are Russian producers ready to develop new markets and competences? What role do state corporations and large holding companies play in developing the production of materials, components, and raw materials?

Aleksandr Petrov, Head of the Expert Council for Regulating the Circulation of Medicines and Medical Devices, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection

Darya Borisova, Member of the Board – Managing Director for Development and Innovations, SIBUR
Alexander Braverman, First Deputy Chairman, VEB.RF
Dmitriy Galkin, Director of Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of the Russian Federation
Danica Grujicic, Minister of Health of the Republic of Serbia
Rajiv Kumar, General Director, Raymed Trading Group
Victor Fisenko, First Deputy Minister of Health of the Russian Federation (online)
Evgeniya Shapiro, Director General, PSK Pharma

Front row participant
Vsevolod Belousov, Director, "Federal Center of Brain Research and Neurotechnologies" of the Federal Medical Biological Agency